Related Experiment Video
Updated: Jan 18, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Hyperosmolar Hyperglycemic State With Reversible Encephalopathy in a Young Female on Chronic Steroids and Opioids: A
11st Propaedeutic Internal Medicine Department, American Hellenic Educational Progressive Association (AHEPA) University Hospital, Thessaloniki, GRC.
None:
Hyperosmolar hyperglycemic state (HHS) is uncommon in young adults and may signal complex metabolic and pharmacologic interactions, particularly in the context of chronic glucocorticoid and opioid exposure. We describe a 22-year-old female with morbid obesity, idiopathic intracranial hypertension treated with ventriculoperitoneal shunting and neuromodulation, chronic high-dose steroid use, and opioid exposure who presented with severe hyperglycemia, dehydration, headache, and transient confusion. Laboratory findings revealed glucose level of 583 mg/dL, calculated osmolality of approximately 318 mOsm/kg, preserved C-peptide indicating severe insulin resistance, and suppressed adrenocorticotropic hormone and cortisol consistent with exogenous steroid-induced hypothalamic-pituitary-adrenal axis suppression. Urine ketones were present, but serum ketones were absent, supporting HHS without ketoacidosis. Neuroimaging excluded acute intracranial pathology. The patient improved with intravenous fluids, insulin therapy, treatment of intercurrent infection, and careful steroid tapering, achieving full neurologic recovery. This case highlights the potential for hyperosmolar neuro-metabolic crisis in young adults with chronic steroid and opioid exposure and emphasizes the importance of considering HHS in atypical populations, particularly when obesity, prolonged glucocorticoid therapy, and central nervous system depressants coexist.
More Related Videos
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Acute Pancreatitis II: Clinical Manifestations and Management
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

